Monte Rosa Therapeutics Company
Monte Rosa Therapeutics is a biotech company that focuses on developing cancer treatments by targeting disease-causing proteins for degradation. They have a drug discovery platform that promotes protein ubiquitination and proteasomal degradation, leading to pharmacological protein knockout with high efficiency and accuracy. Their approach aims to deliver innovative therapies for cancer and other diseases.
Investors
Headquarters:
Basel
Technology:
Pharmaceuticals, R&D
Industry:
BioTech
Estimated Revenue:
9.5